‘Havana syndrome’: what US intelligence concluded, and why the dispute won’t settle
Since 2016, US officials abroad have reported strange sensory experiences followed by symptoms; most US intelligence agencies judged a foreign attack very unlikely, but dissenting agencies, a House committee and new developments keep the question open.
What’s claimed
Beginning in Havana in late 2016, US diplomats and intelligence officers reported strange sensory experiences followed by symptoms such as headaches, dizziness and trouble concentrating. The cases became known as "Havana syndrome"; the US government calls them anomalous health incidents, or AHIs. Many of those affected, and some members of Congress, believe they were deliberately targeted by a foreign adversary, possibly with a weapon using radiofrequency energy, which two US intelligence agencies have called a plausible cause.
What’s on the record
On March 1, 2023, the US intelligence community published an updated assessment. Most agencies concluded it was very unlikely that a foreign adversary was responsible: two with moderate-to-high confidence and three with moderate confidence. Two agencies judged it only unlikely, with low confidence. Investigators had looked at hundreds of reported incidents, could not identify an adversary as responsible for any of them, and found no credible evidence that an adversary had a weapon or device causing AHIs. The assessment said the symptoms were probably the result of factors such as preexisting conditions, conventional illnesses and environmental factors, and stressed that every agency agreed those affected had reported their experiences sincerely. It also listed what would make it look again: new medical evidence of a distinct syndrome, or a specific device fielded by an adversary.
On March 18, 2024, National Institutes of Health researchers published a study in JAMA of 86 people who reported AHIs and 30 matched controls. Headache, cognitive difficulties and sleep problems were the most common symptoms reported, but the study found no significant differences from the controls on most clinical, research and biomarker measures; the exceptions included balance and some psychological measures. Twenty-eight per cent of the AHI participants had functional neurological disorders.
The other side
On December 5, 2024, the House Intelligence Committee released an unclassified report saying it appeared increasingly likely that a foreign adversary was behind some cases, and that the 2023 assessment "lacked analytic integrity and was highly irregular in its formulation," as reported by CBS News. In January 2025 an update found five of seven intelligence components still judged foreign involvement very unlikely, but two had shifted; one now saw a "roughly even chance" that a foreign actor had used a novel weapon against a small number of US personnel. All agreed that no compelling intelligence tied a foreign actor to any specific incident.
Since then, the ground has shifted. DefenseScoop reported in February 2026 that the US government, with Pentagon funding, had bought a device that might be connected to AHIs in the final weeks of the Biden administration, as first reported by CBS in January, and that the earlier intelligence findings were reportedly under review by the Office of the Director of National Intelligence. That month the Pentagon moved its AHI team to its research and engineering directorate to work on treatments and countermeasures. In July 2026 it said it had paid nearly $3 million in compensation, the first payments under the HAVANA Act by any administration, and renamed the team for directed-energy bio-effects.
Still open
The earlier intelligence findings were reportedly under review by the Office of the Director of National Intelligence as of February 2026. Little is public about the device the government bought, beyond that it might be connected to AHIs. The 2023 assessment itself named what would make it look again: new medical evidence of a distinct syndrome, or a specific device fielded by an adversary. All agencies agreed no compelling intelligence tied a foreign actor to any specific incident.
Where it stands (for now)
Under Review. The intelligence community’s last published judgment is that a foreign attack is very unlikely, and a major NIH study found no significant differences from controls on most clinical, research and biomarker measures. Two agencies dissent, a House committee calls the process flawed, and the government has bought a device that might be connected while the findings are reviewed.
Sources
-
Document
Updated Assessment of Anomalous Health Incidents (ICA 2023-02286-B)
· Office of the Director of National Intelligence (National Intelligence Council) · Feb. 28, 2023
“most IC agencies have concluded that it is "very unlikely" a foreign adversary is responsible for the reported AHIs.” - Document Clinical, Biomarker, and Research Tests Among US Government Personnel and Their Family Members Involved in Anomalous Health Incidents · JAMA (National Institutes of Health researchers) · March 17, 2024
- News Foreign adversary was likely behind Havana Syndrome, House Intelligence leaders say · CBS News · Dec. 4, 2024
- News US intelligence mostly rejects links between ‘Havana Syndrome,’ adversaries · Voice of America · Jan. 9, 2025
- News Pentagon eyes ‘treatments and countermeasures’ as it reshapes AHI cross-functional team · DefenseScoop · Feb. 23, 2026
- News Pentagon disburses Havana Syndrome compensation, rebrands team focused on ‘Directed Energy Bio-Effects’ · DefenseScoop · July 12, 2026
More: the case files, every source behind every story.